1. Home
  2. DCGO vs CALC Comparison

DCGO vs CALC Comparison

Compare DCGO & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.88

Market Cap

97.4M

Sector

Health Care

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.20

Market Cap

91.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
CALC
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.4M
91.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DCGO
CALC
Price
$0.88
$6.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$3.33
$14.50
AVG Volume (30 Days)
663.4K
149.0K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$368,093,385.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$1.42
52 Week High
$5.68
$6.40

Technical Indicators

Market Signals
Indicator
DCGO
CALC
Relative Strength Index (RSI) 35.94 77.74
Support Level $0.88 $4.64
Resistance Level $0.99 $6.40
Average True Range (ATR) 0.06 0.51
MACD -0.00 0.14
Stochastic Oscillator 1.12 96.98

Price Performance

Historical Comparison
DCGO
CALC

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: